Grab Holdings Ltd

**Signal Note: Driehaus Capital Initiates $54.9M Position in Grab Holdings** This signal is a **false positive for biotech analysis**—Grab is a Southeast Asian ride-hailing and fintech platform, not a biopharmaceutical company. Driehaus's entry reflects exposure to emerging market digital commerce, not drug development or clinical catalysts. The position is outside traditional biotech sector dynamics and unlikely to correlate with pipeline de-risking or regulatory milestones typical of growth-stage therapeutics.